Tatva Chintan Pharma - Quaterly Results

28 Jan 2025 Evaluate
Revenue reduced marginally to stand at Rs. 839.99 millions during the quarter ended December 2024. The figure stood at Rs. 860.69 millions during the year-ago period.The Net Loss for the quarter ended December 2024 is Rs. -11.65 millions as compared to Net Profit of Rs. 46.51 millions of corresponding quarter ended December 2023A decline of 56.86 millions was observed in the OP in the quarter ended December 2024 from 135.22 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 839.99 860.69 -2.41 2587.67 2847.47 -9.12 3786.77 4030.44 -6.05
Other Income 0.40 12.09 -96.69 22.66 29.80 -23.96 75.08 56.78 32.23
PBIDT 56.86 135.22 -57.95 202.07 556.47 -63.69 743.73 603.56 23.22
Interest 4.16 3.77 10.34 9.02 62.89 -85.66 65.07 83.84 -22.39
PBDT 52.70 131.45 -59.91 193.05 493.58 -60.89 678.66 483.85 40.26
Depreciation 69.23 65.82 5.18 203.98 193.69 5.31 256.01 95.54 167.96
PBT -16.53 65.63 -125.19 -10.93 299.89 -103.64 422.65 388.31 8.84
TAX -4.88 19.12 -125.52 -3.25 88.87 -103.66 129.17 -16.34 -890.51
Deferred Tax -4.32 5.91 -173.10 -3.41 36.70 -109.29 55.74 -35.93 -255.13
PAT -11.65 46.51 -125.05 -7.68 211.02 -103.64 293.48 404.65 -27.47
Equity 233.92 233.92 0.00 233.92 233.92 0.00 233.92 221.65 5.54
PBIDTM(%) 6.77 15.71 -56.91 7.81 19.54 -60.04 19.64 14.98 31.15

Tatva Chintan Pharma Share Price

1387.00 -31.50 (-2.22%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
BASF India 4039.90
Tata Chemicals 773.85
SRF 2886.20
Pidilite Inds. 1474.70
Deepak Nitrite 1565.30
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×